Mohammad Hossein Mohammadi
Overview
Explore the profile of Mohammad Hossein Mohammadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
896
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soleimani Samarkhazan H, Zehtabcheh S, Seraji H, Beqaj S, Tayefeh S, Mohammadi M, et al.
Biomark Res
. 2025 Feb;
13(1):28.
PMID: 39940055
Acute myeloid leukemia (AML) remains a formidable blood cancer, despite recent advances in treatment. A significant challenge persists in improving patient outcomes, particularly in addressing relapse and treatment resistance. Identifying...
2.
Ivriq S, Mohammadi M, Davidsen R
Sci Rep
. 2025 Jan;
15(1):1478.
PMID: 39789094
Significant progress has been made through the optimization of modelling and device architecture solar cells has proven to be a valuable and highly effective approach for gaining a deeper understanding...
3.
Ghorbani M, Bashash D, Gheydari M, Mohammadi M, Shahraki H, Yazdanparast S, et al.
Health Sci Rep
. 2024 Dec;
7(12):e70209.
PMID: 39669190
Background And Aims: Acute coronary syndrome (ACS) is one of the most important cardiovascular diseases. The rupture of atherosclerotic plaques in coronary arteries is considered the underlying pathophysiology of ACS....
4.
Shahraki H, Gheydari M, Mohammadi M, Bashash D, Ghorbani M, Mirsattari D, et al.
Cell J
. 2024 Sep;
26(7):454-464.
PMID: 39290123
Objective: Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with atherosclerosis serving as a primary factor in their development. Platelets, leukocytes, and their interactions play a crucial role...
5.
Younesian S, Mohammadi M, Younesian O, Momeny M, Ghaffari S, Bashash D
Heliyon
. 2024 Jun;
10(11):e32366.
PMID: 38933971
Aberrant epigenetic modifications, particularly DNA methylation, play a critical role in the pathogenesis and progression of human diseases. The current review aims to reveal the role of aberrant DNA methylation...
6.
Keshavarz A, Navidinia A, Kuhestani Dehaghi B, Amiri V, Mohammadi M, Farsani M
Mol Biotechnol
. 2024 May;
PMID: 38714601
Acute myeloid leukemia (AML) is a lethal hematologic malignancy with a variable prognosis that is highly dependent on the bone marrow microenvironment. Consequently, a better understanding of the AML microenvironment...
7.
Saharkhiz N, Hajizadeh N, Alkhafaji J, Mohammadi M
JBRA Assist Reprod
. 2024 Apr;
28(3):424-429.
PMID: 38640352
Objective: Premature ovary failure (POF) is a severe health condition with multiple negative outcomes, which deteriorate a patient's life. The current study aimed to evaluate the therapeutic effect of mesenchymal...
8.
Abbaszade Dibavar M, Soleimani M, Mohammadi M, Soufi Zomorrod M
In Vitro Cell Dev Biol Anim
. 2024 Apr;
60(4):321-332.
PMID: 38589736
Chimeric antigen receptors (CARs) offer a promising new approach for targeting B cell malignancies through the immune system. Despite the proven effectiveness of CAR T cells targeting CD19 and CD22...
9.
Asghari-Ghomi A, Fallahian F, Garavand J, Mohammadi M
Mol Biol Rep
. 2024 Feb;
51(1):244.
PMID: 38300383
Background: Relapse following hematopoietic stem cell transplantation (HSCT) occurs relatively frequently and is a significant risk factor for mortality in patients with acute myeloid leukemia (AML). Early diagnosis is, therefore,...
10.
Gorji M, Farsani M, Kargar M, Garavand J, Mohammadi M
Curr Res Transl Med
. 2024 Jan;
72(2):103429.
PMID: 38246071
Background: Acute myeloid leukemia (AML) has been the most prevalent form of acute leukemia among adults, and it has been associated with poor survival rates over the last four decades....